sb 239063 has been researched along with anisomycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, W; Chai, W; Li, G; Liu, Z; Wu, Y; Yang, Z | 1 |
1 other study(ies) available for sb 239063 and anisomycin
Article | Year |
---|---|
Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Topics: Animals; Anisomycin; Cardiotonic Agents; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Hypoglycemic Agents; Imidazoles; Insulin; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Reperfusion Injury; Myocardium; p38 Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley | 2008 |